Improving diagnosis and treatment for meningitis in HIV/AIDS patients
Midcareer Mentoring for Clinical Research in HIV/AIDS-related cryptococcal and TB meningitis
This study is all about finding better ways to diagnose and treat serious brain infections like cryptococcal and TB meningitis that can affect people with weakened immune systems, especially those living with HIV/AIDS, so we can help improve their health and care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10924701 on NIH RePORTER |
What this research studies
This research focuses on enhancing the understanding and management of central nervous system infections, particularly cryptococcal and TB meningitis, which significantly affect individuals with weakened immune systems, such as those living with HIV/AIDS. The project aims to develop better diagnostic tools, treatment protocols, and supportive care strategies through clinical trials and mentoring of new researchers in the field. By addressing these neglected diseases, the research seeks to influence international medical guidelines and improve patient outcomes across various income settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are living with HIV/AIDS and are at risk for cryptococcal or TB meningitis.
Not a fit: Patients who do not have HIV/AIDS or are not at risk for central nervous system infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis, treatment, and prevention strategies for meningitis in patients with HIV/AIDS, potentially reducing mortality and disability rates.
How similar studies have performed: Previous research has shown success in improving outcomes for patients with similar conditions through enhanced diagnostic and treatment strategies, indicating a promising potential for this approach.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Boulware, David R — University of Minnesota
- Study coordinator: Boulware, David R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.